Results 121 to 130 of about 4,951 (135)

Comment on the firsts insights of the arterial hypertension study in México (RIHTA): are we doing things right? [PDF]

Arch Cardiol Mex
Aguilar-López R, Rojas-Velasco G, Toledo-Elías R.   +2 more
europepmc   +1 more source

From Cholesterol Metabolism to Comprehensive Lipid Management and Crosstalk of Inflammation: Expanding the Frontiers of Cardiovascular Prevention. [PDF]

Arq Bras Cardiol
Vilela E, Bettencourt N.
europepmc   +1 more source

[Beyond the plaque: immunological implications of risk factors in atherosclerosis]. [PDF]

Arch Cardiol Mex
Aguilar-Villegas ÓR, Barragán-Los Santos J, Del Moral-Wong LE, Amezcua-Guerra LM, Aguirre-García MM.   +4 more
europepmc   +1 more source

From Atheroma to Atherogenic Index, Secular Evidence. [PDF]

Arq Bras Cardiol
Precoma DB, Rocha GLD.
europepmc   +1 more source

[Effectiveness of the CNIC polypill in secondary cardiovascular prevention in the subgroup of patients of the NEPTUNO study using atorvastatin doses of 20 mg]. [PDF]

Arch Cardiol Mex
González-Juanatey JR, Cordero A, Masana L, Dalmau R.   +3 more
europepmc   +1 more source

Aspectos fundamentales en la solicitud y determinación de la lipoproteína(a) en el laboratorio clínico. [PDF]

Adv Lab Med
Arrobas Velilla T, Fernández Prendes C, Amigó Grau N, Calmarza P, Camós Anguila S, Candas Estébanez B, Castro Castro MJ, Ceacero D, González Martínez I, Martín Palencia M, Puzo Foncillas J, Romero Román C, en nombre de la Comisión de Lipoproteínas y Enfermedades Cardiovasculares de la SEQCML.   +12 more
europepmc   +1 more source

[Impact of obesity and diabetes on health and cardiovascular disease]. [PDF]

Aten Primaria
Lecube A.
europepmc   +1 more source

[Dyslipidemia in high cardiovascular risk patients. Initial results from the REMEXDIS-IMSS study]. [PDF]

Rev Med Inst Mex Seguro Soc
Machuca-Loeza MG, Fernández-Hernández JP, Gutiérrez-Galván MX, Borrayo-Sánchez G, Cruz-Aceves I, Solorio-Meza SE, Hernández-González MA.   +6 more
europepmc   +1 more source

[Childhood family strengths and cardiometabolic risk in adults from a clinical setting of Michoacán, Mexico]. [PDF]

Aten Primaria
Hipólito Mendoza HV, Gómez Garcia A, Ibarra Rojas L, Chacón-Valladares P, Lajud N.   +4 more
europepmc   +1 more source